Top managers continue to exercise a lot of patience as they look for buying opportunities in a U.S. equity market that has risen close to 40% since the start of 2013.
Research and Markets: Global Medical Imaging Reagents Market 2013-2019
Research and Markets: Genetic Testing (Prenatal and Newborn Genetic Testing, Pharmacogenomic Testing, and Predictive Testing) - Global Strategic Business Report
Research and Markets: Global Human Identification Market Report 2014-2018: Technology, Application, DNA Amplification, Quantification, Extraction, Services, & Software Analysis
Recent sell-off provides dozens of buying opportunities.
Research and Markets: PCR Technologies Global Market - Forecast to 2019
Research and Markets: Global Market for Biomarkers Report: Cancer, Cardiac, Blood, Endocrine, Infectious Disease and Neurological Disease Markers
A handful of analyst-recommended moderate-allocation funds have proved their mettle in good times and bad.